Q3 2026 Blue Jet Healthcare Ltd Earnings Call Transcript
Key Points
- Blue Jet Healthcare Ltd (NSE:BLUEJET) announced the groundbreaking ceremony for its Vizag Greenfield project, which is expected to be a pivotal growth platform with a total investment of INR1,000 crores over the next three to four years.
- The company has successfully secured lease space for R&D activities in Hyderabad, which will commence from Q3 FY27, enhancing its innovation pipeline and technical capabilities.
- Blue Jet Healthcare Ltd is expanding its artificial sweetener pipeline, which will complement its existing high-intensity sweetener portfolio and address growing global demand.
- The company is nearing completion of its Unit III expansion project, which will play a key role in debottlenecking the supply chain and supporting future growth.
- Blue Jet Healthcare Ltd has embedded sustainability into its operations, with 70% of its power consumption now met through wind and solar energy, and has been recognized with the National Award for Excellence in Energy Management.
- Revenue from operations decreased by 40% year-on-year, with EBITDA decreasing by 62% and PAT decreasing by 39%, indicating significant financial challenges.
- The company experienced a gross margin decline to 52% in Q3, attributed to a change in product mix and a one-time inventory write-off.
- There is a destocking impact and supply chain realignment affecting orders, which may take a couple of quarters to resolve.
- The company faced negative operating leverage due to lower sales volume and one-time impacts such as labor code implementation and foreign consultant engagement.
- The recent moderation in operating cash flow and the announced INR1,000 crores CapEx program raise concerns about funding and potential leverage or dilution.
Ladies and gentlemen, good day, and welcome to Blue Jet Healthcare Limited Q3 FY26 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
For cautionary remarks, I now hand the conference over to Mr. Advait Bhadekar from Ernst & Young. Thank you, and over to you, sir.
Thank you, Bhoomi. Good evening, and a warm welcome, everyone, to Q3 and 9M FY26 earnings call of Blue Jet Healthcare Limited. Please note, the investor presentation and the financial results are available on the company website and the stock exchanges. Also, anything said on this call, which reflects our outlook for the future or which could be construed as a forward-looking statement must be reviewed in conjunction with the risks that the company faces.
The conference call is being recorded, and the transcript along with the audio of the same will be made available on the website of the company as well as on the exchanges. Please also note that the audio of the conference
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
